UniProt ID | MYPC2_HUMAN | |
---|---|---|
UniProt AC | Q14324 | |
Protein Name | Myosin-binding protein C, fast-type | |
Gene Name | MYBPC2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1141 | |
Subcellular Localization | ||
Protein Description | Thick filament-associated protein located in the crossbridge region of vertebrate striated muscle a bands. In vitro it binds MHC, F-actin and native thin filaments, and modifies the activity of actin-activated myosin ATPase. It may modulate muscle contraction or may play a more structural role.. | |
Protein Sequence | MPEAKPAAKKAPKGKDAPKGAPKEAPPKEAPAEAPKEAPPEDQSPTAEEPTGVFLKKPDSVSVETGKDAVVVAKVNGKELPDKPTIKWFKGKWLELGSKSGARFSFKESHNSASNVYTVELHIGKVVLGDRGYYRLEVKAKDTCDSCGFNIDVEAPRQDASGQSLESFKRTSEKKSDTAGELDFSGLLKKREVVEEEKKKKKKDDDDLGIPPEIWELLKGAKKSEYEKIAFQYGITDLRGMLKRLKKAKVEVKKSAAFTKKLDPAYQVDRGNKIKLMVEISDPDLTLKWFKNGQEIKPSSKYVFENVGKKRILTINKCTLADDAAYEVAVKDEKCFTELFVKEPPVLIVTPLEDQQVFVGDRVEMAVEVSEEGAQVMWMKDGVELTREDSFKARYRFKKDGKRHILIFSDVVQEDRGRYQVITNGGQCEAELIVEEKQLEVLQDIADLTVKASEQAVFKCEVSDEKVTGKWYKNGVEVRPSKRITISHVGRFHKLVIDDVRPEDEGDYTFVPDGYALSLSAKLNFLEIKVEYVPKQEPPKIHLDCSGKTSENAIVVVAGNKLRLDVSITGEPPPVATWLKGDEVFTTTEGRTRIEKRVDCSSFVIESAQREDEGRYTIKVTNPVGEDVASIFLQVVDVPDPPEAVRITSVGEDWAILVWEPPMYDGGKPVTGYLVERKKKGSQRWMKLNFEVFTETTYESTKMIEGILYEMRVFAVNAIGVSQPSMNTKPFMPIAPTSEPLHLIVEDVTDTTTTLKWRPPNRIGAGGIDGYLVEYCLEGSEEWVPANTEPVERCGFTVKNLPTGARILFRVVGVNIAGRSEPATLAQPVTIREIAEPPKIRLPRHLRQTYIRKVGEQLNLVVPFQGKPRPQVVWTKGGAPLDTSRVHVRTSDFDTVFFVRQAARSDSGEYELSVQIENMKDTATIRIRVVEKAGPPINVMVKEVWGTNALVEWQAPKDDGNSEIMGYFVQKADKKTMEWFNVYERNRHTSCTVSDLIVGNEYYFRVYTENICGLSDSPGVSKNTARILKTGITFKPFEYKEHDFRMAPKFLTPLIDRVVVAGYSAALNCAVRGHPKPKVVWMKNKMEIREDPKFLITNYQGVLTLNIRRPSPFDAGTYTCRAVNELGEALAECKLEVRVPQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
44 | Phosphorylation | EAPPEDQSPTAEEPT CCCCCCCCCCCCCCC | 36.22 | 19764811 | |
46 | Phosphorylation | PPEDQSPTAEEPTGV CCCCCCCCCCCCCEE | 52.53 | 19764811 | |
60 | Phosphorylation | VFLKKPDSVSVETGK EEECCCCCEEEEECC | 25.48 | 26437602 | |
62 | Phosphorylation | LKKPDSVSVETGKDA ECCCCCEEEEECCCE | 20.42 | 26437602 | |
98 | Phosphorylation | GKWLELGSKSGARFS CCEEECCCCCCCEEE | 35.95 | 26437602 | |
105 | Phosphorylation | SKSGARFSFKESHNS CCCCCEEEEECCCCC | 29.83 | 23927012 | |
112 | Phosphorylation | SFKESHNSASNVYTV EEECCCCCCCCEEEE | 27.87 | 26437602 | |
114 | Phosphorylation | KESHNSASNVYTVEL ECCCCCCCCEEEEEE | 27.01 | 26437602 | |
118 | Phosphorylation | NSASNVYTVELHIGK CCCCCEEEEEEEEEE | 11.83 | 26437602 | |
167 | Phosphorylation | ASGQSLESFKRTSEK CCCCCHHHHHCCCCC | 41.16 | 26437602 | |
223 | Acetylation | ELLKGAKKSEYEKIA HHHHCCCHHHHHHHH | 48.24 | 30590527 | |
228 | Acetylation | AKKSEYEKIAFQYGI CCHHHHHHHHHHHCC | 38.13 | 30590533 | |
249 | Acetylation | LKRLKKAKVEVKKSA HHHHHHCCCEECCCH | 48.05 | 19813251 | |
300 | Phosphorylation | GQEIKPSSKYVFENV CEECCCCCCEEEEEC | 36.21 | 26437602 | |
409 | Phosphorylation | KRHILIFSDVVQEDR CEEEEEEECCEECCC | 23.62 | 22673903 | |
468 | Phosphorylation | EVSDEKVTGKWYKNG EECCCCCCCEEEECC | 44.08 | 26437602 | |
472 | Phosphorylation | EKVTGKWYKNGVEVR CCCCCEEEECCEEEC | 9.69 | - | |
481 | Phosphorylation | NGVEVRPSKRITISH CCEEECCCCCEEECC | 24.81 | 26437602 | |
487 | Phosphorylation | PSKRITISHVGRFHK CCCCEEECCCCCEEE | 11.94 | 24719451 | |
546 | Phosphorylation | PKIHLDCSGKTSENA CCEEEECCCCCCCCE | 42.88 | 26437602 | |
587 | Phosphorylation | KGDEVFTTTEGRTRI CCCEEEECCCCCCEE | 16.04 | 26437602 | |
722 | Phosphorylation | AVNAIGVSQPSMNTK EEEEECCCCCCCCCC | 31.03 | - | |
820 | Phosphorylation | GVNIAGRSEPATLAQ CEECCCCCCCCCCCC | 47.19 | 26437602 | |
830 | Phosphorylation | ATLAQPVTIREIAEP CCCCCCEEHHHHCCC | 22.47 | 26437602 | |
849 | Phosphorylation | LPRHLRQTYIRKVGE CCHHHHHHHHHHHHH | 17.93 | 24719451 | |
850 | Phosphorylation | PRHLRQTYIRKVGEQ CHHHHHHHHHHHHHH | 7.15 | 26437602 | |
883 | Phosphorylation | KGGAPLDTSRVHVRT ECCCCCCCCEEEEEC | 26.56 | 26437602 | |
884 | Phosphorylation | GGAPLDTSRVHVRTS CCCCCCCCEEEEECC | 31.78 | 26437602 | |
924 | Phosphorylation | ENMKDTATIRIRVVE ECCCCCEEEEEEEEE | 16.93 | 26437602 | |
962 | Phosphorylation | APKDDGNSEIMGYFV CCCCCCCCCEEEEEE | 33.75 | - | |
967 | Phosphorylation | GNSEIMGYFVQKADK CCCCEEEEEEEECCH | 5.34 | - | |
989 | Phosphorylation | VYERNRHTSCTVSDL HHHHCCCCCCCHHHE | 23.43 | 26437602 | |
1003 | Phosphorylation | LIVGNEYYFRVYTEN EEECCEEEEEEEECC | 4.44 | - | |
1007 | Phosphorylation | NEYYFRVYTENICGL CEEEEEEEECCCCCC | 12.22 | - | |
1015 | Phosphorylation | TENICGLSDSPGVSK ECCCCCCCCCCCCCH | 22.71 | - | |
1017 | Phosphorylation | NICGLSDSPGVSKNT CCCCCCCCCCCCHHH | 21.85 | 26437602 | |
1078 | Ubiquitination | VRGHPKPKVVWMKNK HCCCCCCCEEEECCC | 56.39 | - | |
1085 | "N6,N6-dimethyllysine" | KVVWMKNKMEIREDP CEEEECCCEECCCCC | 32.18 | - | |
1085 | Methylation | KVVWMKNKMEIREDP CEEEECCCEECCCCC | 32.18 | - | |
1099 | Phosphorylation | PKFLITNYQGVLTLN CCEEEECCCCEEEEE | 9.67 | - | |
1104 | Phosphorylation | TNYQGVLTLNIRRPS ECCCCEEEEEECCCC | 18.49 | - | |
1111 | Phosphorylation | TLNIRRPSPFDAGTY EEEECCCCCCCCCCC | 36.07 | 26437602 | |
1117 | Phosphorylation | PSPFDAGTYTCRAVN CCCCCCCCCCHHHHH | 19.85 | 24043423 | |
1118 | Phosphorylation | SPFDAGTYTCRAVNE CCCCCCCCCHHHHHH | 11.70 | 24043423 | |
1119 | Phosphorylation | PFDAGTYTCRAVNEL CCCCCCCCHHHHHHH | 8.71 | 24043423 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MYPC2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MYPC2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of MYPC2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-105, AND MASSSPECTROMETRY. |